Abacavir
- Strength
- 300 mg/1
- Form
- Tablet
- Class
- Human Immunodeficiency Virus Nucleoside…
Camber Pharmaceuticals, Inc.
Listed by Major Pharmaceuticals
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 0904-6874 |
| FDA application | ANDA077844 |
| RxNorm concept | 242679 |
| Package sizes listed | 2 |
| Marketed since | December 2012 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Camber Pharmaceuticals, Inc.
Coupler LLC
AvPAK
American Health Packaging
Cipla USA Inc.
Camber Pharmaceuticals, Inc.
Abacavir Sulfate
Aurobindo Pharma Limited
Abacavir Sulfate
Rising Pharma Holdings, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.